Insight into nanoliposomes as smart nanocarriers for greening the twenty-first century biomedical settings

KM Aguilar-Pérez, JI Avilés-Castrillo… - … in Bioengineering and …, 2020 - frontiersin.org
The necessity to develop more efficient, biocompatible, patient compliance, and safer
treatments in biomedical settings is receiving special attention using nanotechnology as a …

Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems

MT Luiz, JSR Viegas, JP Abriata, F Viegas… - European Journal of …, 2021 - Elsevier
Nanotechnology has been widely applied to develop drug delivery systems to improve
therapeutic performance. The effectiveness of these systems is intrinsically related to their …

Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity …

MS Shahab, M Rizwanullah, S Alshehri… - International journal of …, 2020 - Elsevier
The present research work was designed to develop dorzolamide-loaded chitosan-coated
polycaprolactone nanoparticles (DRZ-CS-PCL-NPs) for improved ocular delivery. The …

Spanlastics a novel nanovesicular carrier: its potential application and emerging trends in therapeutic delivery

MD Ansari, Z Saifi, J Pandit, I Khan, P Solanki… - AAPS …, 2022 - Springer
Nanotechnology-based drug delivery system has played a very crucial role in overpowering
the tasks allied with the conventional dosage form. Spanlastics, an elastic nanovesicle with …

Critical review of lipid-based nanoparticles as carriers of neuroprotective drugs and extracts

F Fernandes, M Dias-Teixeira, C Delerue-Matos… - Nanomaterials, 2021 - mdpi.com
The biggest obstacle to the treatment of diseases that affect the central nervous system
(CNS) is the passage of drugs across the blood-brain barrier (BBB), a physical barrier that …

Application of quality by design in optimization of nanoformulations: Principle, perspectives and practices

D Birla, N Khandale, B Bashir, M ShahbazAlam… - Drug Delivery and …, 2024 - Springer
Nanoparticulate drug delivery systems (NDDS) based nanoformulations have emerged as
promising drug delivery systems. Various NDDS-based formulations have been reported …

Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis

S Pandey, N Rai, A Mahtab, D Mittal, FJ Ahmad… - International Journal of …, 2021 - Elsevier
Rheumatoid arthritis (RA), an autoimmune inflammatory disorder is currently incurable.
Methotrexate and Teriflunomide are routinely prescribed drugs but their uses are limited due …

Facile functionalization of Teriflunomide-loaded nanoliposomes with Chondroitin sulphate for the treatment of Rheumatoid arthritis

A Mahtab, SA Rabbani, YR Neupane, S Pandey… - Carbohydrate …, 2020 - Elsevier
This research aims to coat Teriflunomide (TEF) loaded conventional nanoliposomes (CON-
TEF-LIPO) with Chondroitin sulphate (CS) to produce CS-TEF-LIPO for the effective …

Current insight into the therapeutic potential of phytocompounds and their nanoparticle-based systems for effective management of lung cancer

M Fatima, MK Iqubal, A Iqubal, H Kaur… - Anti-Cancer Agents …, 2022 - ingentaconnect.com
Lung cancer is the second most common cancer and the primary cause of cancer-related
death in both men and women worldwide. Due to diagnosis at an advanced stage, it is …

[HTML][HTML] Is it advantageous to use quality by design (QbD) to develop nanoparticle-based dosage forms for parenteral drug administration?

CC Vieira, L Peltonen, AP Karttunen… - International Journal of …, 2024 - Elsevier
Parenteral administration is one of the most commonly used drug delivery routes for
nanoparticle-based dosage forms, such as lipid-based and polymeric nanoparticles. For the …